However, current evidence suggests that SLC26A9 protein expression is reduced in CF cells because of its interaction with F508del-CFTR at the level of the ER, and thus it also fails to traffic to the cells’ surface [91,92]. Here, SLC26A9 is linked to cystic fibrosis.